Identifying ways to prevent pulmonary fibrosis in children and young adults.
Official title: Clinical Core
Funded at University of Michigan at Ann Arbor · NIH-10846184 · Data updated 2026-11-12
This study is looking at how pulmonary fibrosis starts in kids and young adults who are at risk but not showing any symptoms yet, and it needs participants to help find ways to prevent the disease before it gets worse.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project start | September 17, 2024 |
| Project end | July 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $636,177 |
| NIH project number | 1P01HL172729-01 |
| Project ID | NIH-10846184 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are children and young adults under 21 years old who have a family history of pulmonary fibrosis.
✕Less likely to help
Patients who are already symptomatic or diagnosed with pulmonary fibrosis may not benefit from this research.
What this research studies
This research focuses on understanding the early biological changes that lead to pulmonary fibrosis (PF) in children and young adults. By studying individuals who are at risk but not yet showing symptoms, the research aims to identify critical factors that contribute to the disease's progression. Participants will undergo various assessments, including advanced imaging and blood tests, to help researchers gather valuable data. The goal is to develop new strategies for prevention and intervention during the pre-symptomatic phase of PF.
Why it matters
Potential benefit: If successful, this research could lead to new preventive measures and treatments for pulmonary fibrosis in young patients.
How similar studies have gone: Previous research has shown promise in identifying early biomarkers for pulmonary fibrosis, suggesting that this approach could yield valuable insights.
Where this research is happening
-
University of Michigan at Ann Arbor
Ann Arbor, United States Active
Researchers
- Principal investigator: Salisbury, Margaret Louise — University of Michigan at Ann Arbor
- Study coordinator: Salisbury, Margaret Louise
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.